nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—CYP2D6—Hydroxyurea—head and neck cancer	0.359	0.739	CbGbCtD
Labetalol—CYP2D6—Vinblastine—head and neck cancer	0.127	0.261	CbGbCtD
Labetalol—Erythema facial—Hydroxyurea—head and neck cancer	0.0427	0.0872	CcSEcCtD
Labetalol—Lupus erythematosus—Hydroxyurea—head and neck cancer	0.021	0.0427	CcSEcCtD
Labetalol—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.0141	0.0288	CcSEcCtD
Labetalol—Colitis ischaemic—Docetaxel—head and neck cancer	0.0138	0.0281	CcSEcCtD
Labetalol—Isoprenaline—MAPK1—head and neck cancer	0.0131	0.538	CrCbGaD
Labetalol—Drug fever—Docetaxel—head and neck cancer	0.0121	0.0248	CcSEcCtD
Labetalol—Lupus erythematosus—Docetaxel—head and neck cancer	0.0109	0.0222	CcSEcCtD
Labetalol—Numbness—Vinblastine—head and neck cancer	0.0103	0.0211	CcSEcCtD
Labetalol—Sensory loss—Vinblastine—head and neck cancer	0.00988	0.0202	CcSEcCtD
Labetalol—Raised liver function tests—Docetaxel—head and neck cancer	0.00878	0.0179	CcSEcCtD
Labetalol—Blood urea increased—Hydroxyurea—head and neck cancer	0.00737	0.015	CcSEcCtD
Labetalol—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.00732	0.0149	CcSEcCtD
Labetalol—Tingling sensation—Fluorouracil—head and neck cancer	0.00699	0.0143	CcSEcCtD
Labetalol—Numbness—Fluorouracil—head and neck cancer	0.00678	0.0138	CcSEcCtD
Labetalol—Sensory loss—Fluorouracil—head and neck cancer	0.00648	0.0132	CcSEcCtD
Labetalol—Disorientation—Hydroxyurea—head and neck cancer	0.00633	0.0129	CcSEcCtD
Labetalol—Throat sore—Docetaxel—head and neck cancer	0.00563	0.0115	CcSEcCtD
Labetalol—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00558	0.0114	CcSEcCtD
Labetalol—Angina pectoris—Vinblastine—head and neck cancer	0.00523	0.0107	CcSEcCtD
Labetalol—Depression—Vinblastine—head and neck cancer	0.00477	0.00974	CcSEcCtD
Labetalol—Dysuria—Hydroxyurea—head and neck cancer	0.00458	0.00934	CcSEcCtD
Labetalol—Disorientation—Fluorouracil—head and neck cancer	0.00456	0.0093	CcSEcCtD
Labetalol—Agranulocytosis—Vinblastine—head and neck cancer	0.00447	0.00911	CcSEcCtD
Labetalol—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00446	0.0091	CcSEcCtD
Labetalol—Drowsiness—Hydroxyurea—head and neck cancer	0.00437	0.00891	CcSEcCtD
Labetalol—Amnesia—Fluorouracil—head and neck cancer	0.00434	0.00885	CcSEcCtD
Labetalol—Hypoaesthesia—Vinblastine—head and neck cancer	0.00428	0.00872	CcSEcCtD
Labetalol—Cardiac failure—Fluorouracil—head and neck cancer	0.00418	0.00852	CcSEcCtD
Labetalol—Lethargy—Fluorouracil—head and neck cancer	0.00416	0.00849	CcSEcCtD
Labetalol—Hallucination—Hydroxyurea—head and neck cancer	0.0039	0.00796	CcSEcCtD
Labetalol—Alopecia—Vinblastine—head and neck cancer	0.0038	0.00775	CcSEcCtD
Labetalol—Ill-defined disorder—Vinblastine—head and neck cancer	0.00347	0.00708	CcSEcCtD
Labetalol—Alopecia—Hydroxyurea—head and neck cancer	0.00346	0.00707	CcSEcCtD
Labetalol—Angina pectoris—Fluorouracil—head and neck cancer	0.00343	0.007	CcSEcCtD
Labetalol—Erythema—Hydroxyurea—head and neck cancer	0.00341	0.00696	CcSEcCtD
Labetalol—Malaise—Vinblastine—head and neck cancer	0.00337	0.00688	CcSEcCtD
Labetalol—Vertigo—Vinblastine—head and neck cancer	0.00336	0.00686	CcSEcCtD
Labetalol—Hypertension—Vinblastine—head and neck cancer	0.00323	0.00659	CcSEcCtD
Labetalol—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00317	0.00646	CcSEcCtD
Labetalol—Discomfort—Vinblastine—head and neck cancer	0.00315	0.00642	CcSEcCtD
Labetalol—Malaise—Hydroxyurea—head and neck cancer	0.00308	0.00628	CcSEcCtD
Labetalol—Cardiac failure—Docetaxel—head and neck cancer	0.00302	0.00615	CcSEcCtD
Labetalol—Lethargy—Docetaxel—head and neck cancer	0.003	0.00613	CcSEcCtD
Labetalol—Epistaxis—Fluorouracil—head and neck cancer	0.00296	0.00605	CcSEcCtD
Labetalol—Salsalate—PTGS2—head and neck cancer	0.00296	0.122	CrCbGaD
Labetalol—Agranulocytosis—Fluorouracil—head and neck cancer	0.00293	0.00598	CcSEcCtD
Labetalol—Discomfort—Hydroxyurea—head and neck cancer	0.00287	0.00585	CcSEcCtD
Labetalol—Isoprenaline—CYP1A1—head and neck cancer	0.00282	0.116	CrCbGaD
Labetalol—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00281	0.00573	CcSEcCtD
Labetalol—Oedema—Hydroxyurea—head and neck cancer	0.00278	0.00568	CcSEcCtD
Labetalol—Paraesthesia—Vinblastine—head and neck cancer	0.00274	0.00559	CcSEcCtD
Labetalol—Liver function test abnormal—Docetaxel—head and neck cancer	0.00272	0.00554	CcSEcCtD
Labetalol—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00269	0.00548	CcSEcCtD
Labetalol—Abdominal pain upper—Docetaxel—head and neck cancer	0.00269	0.00548	CcSEcCtD
Labetalol—Cramp muscle—Docetaxel—head and neck cancer	0.00265	0.00541	CcSEcCtD
Labetalol—Pain—Vinblastine—head and neck cancer	0.00261	0.00533	CcSEcCtD
Labetalol—Constipation—Vinblastine—head and neck cancer	0.00261	0.00533	CcSEcCtD
Labetalol—Feeling abnormal—Vinblastine—head and neck cancer	0.00252	0.00513	CcSEcCtD
Labetalol—Bronchospasm—Docetaxel—head and neck cancer	0.0025	0.0051	CcSEcCtD
Labetalol—Gastrointestinal pain—Vinblastine—head and neck cancer	0.0025	0.00509	CcSEcCtD
Labetalol—Alopecia—Fluorouracil—head and neck cancer	0.00249	0.00509	CcSEcCtD
Labetalol—Dyspnoea—Hydroxyurea—head and neck cancer	0.00248	0.00506	CcSEcCtD
Labetalol—Angina pectoris—Docetaxel—head and neck cancer	0.00248	0.00506	CcSEcCtD
Labetalol—Somnolence—Hydroxyurea—head and neck cancer	0.00248	0.00505	CcSEcCtD
Labetalol—Erythema—Fluorouracil—head and neck cancer	0.00246	0.00501	CcSEcCtD
Labetalol—Dyspepsia—Hydroxyurea—head and neck cancer	0.00245	0.005	CcSEcCtD
Labetalol—Fenoprofen—PTGS2—head and neck cancer	0.00245	0.1	CrCbGaD
Labetalol—Abdominal pain—Vinblastine—head and neck cancer	0.00241	0.00492	CcSEcCtD
Labetalol—Fatigue—Hydroxyurea—head and neck cancer	0.0024	0.0049	CcSEcCtD
Labetalol—Pain—Hydroxyurea—head and neck cancer	0.00238	0.00486	CcSEcCtD
Labetalol—Constipation—Hydroxyurea—head and neck cancer	0.00238	0.00486	CcSEcCtD
Labetalol—Vision blurred—Fluorouracil—head and neck cancer	0.00231	0.00472	CcSEcCtD
Labetalol—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00229	0.00468	CcSEcCtD
Labetalol—Hypersensitivity—Vinblastine—head and neck cancer	0.00225	0.00459	CcSEcCtD
Labetalol—Jaundice—Docetaxel—head and neck cancer	0.00221	0.00451	CcSEcCtD
Labetalol—Body temperature increased—Hydroxyurea—head and neck cancer	0.0022	0.00449	CcSEcCtD
Labetalol—Asthenia—Vinblastine—head and neck cancer	0.00219	0.00447	CcSEcCtD
Labetalol—Epistaxis—Docetaxel—head and neck cancer	0.00214	0.00436	CcSEcCtD
Labetalol—Agranulocytosis—Docetaxel—head and neck cancer	0.00212	0.00432	CcSEcCtD
Labetalol—Diarrhoea—Vinblastine—head and neck cancer	0.00209	0.00426	CcSEcCtD
Labetalol—Discomfort—Fluorouracil—head and neck cancer	0.00207	0.00421	CcSEcCtD
Labetalol—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00205	0.00419	CcSEcCtD
Labetalol—Hepatitis—Docetaxel—head and neck cancer	0.00204	0.00415	CcSEcCtD
Labetalol—Hypoaesthesia—Docetaxel—head and neck cancer	0.00203	0.00413	CcSEcCtD
Labetalol—Confusional state—Fluorouracil—head and neck cancer	0.00202	0.00412	CcSEcCtD
Labetalol—Dizziness—Vinblastine—head and neck cancer	0.00202	0.00412	CcSEcCtD
Labetalol—Oedema peripheral—Docetaxel—head and neck cancer	0.00201	0.00409	CcSEcCtD
Labetalol—Anaphylactic shock—Fluorouracil—head and neck cancer	0.002	0.00409	CcSEcCtD
Labetalol—Oedema—Fluorouracil—head and neck cancer	0.002	0.00409	CcSEcCtD
Labetalol—Asthenia—Hydroxyurea—head and neck cancer	0.002	0.00408	CcSEcCtD
Labetalol—Visual impairment—Docetaxel—head and neck cancer	0.00196	0.004	CcSEcCtD
Labetalol—Vomiting—Vinblastine—head and neck cancer	0.00194	0.00396	CcSEcCtD
Labetalol—Headache—Vinblastine—head and neck cancer	0.00191	0.0039	CcSEcCtD
Labetalol—Diarrhoea—Hydroxyurea—head and neck cancer	0.00191	0.00389	CcSEcCtD
Labetalol—Flushing—Docetaxel—head and neck cancer	0.00189	0.00385	CcSEcCtD
Labetalol—Hypotension—Fluorouracil—head and neck cancer	0.00187	0.00382	CcSEcCtD
Labetalol—Dizziness—Hydroxyurea—head and neck cancer	0.00184	0.00376	CcSEcCtD
Labetalol—Nausea—Vinblastine—head and neck cancer	0.00181	0.0037	CcSEcCtD
Labetalol—Paraesthesia—Fluorouracil—head and neck cancer	0.0018	0.00367	CcSEcCtD
Labetalol—Alopecia—Docetaxel—head and neck cancer	0.0018	0.00367	CcSEcCtD
Labetalol—Dyspnoea—Fluorouracil—head and neck cancer	0.00179	0.00365	CcSEcCtD
Labetalol—Mental disorder—Docetaxel—head and neck cancer	0.00178	0.00364	CcSEcCtD
Labetalol—Somnolence—Fluorouracil—head and neck cancer	0.00178	0.00363	CcSEcCtD
Labetalol—Erythema—Docetaxel—head and neck cancer	0.00177	0.00362	CcSEcCtD
Labetalol—Vomiting—Hydroxyurea—head and neck cancer	0.00177	0.00361	CcSEcCtD
Labetalol—Dyspepsia—Fluorouracil—head and neck cancer	0.00176	0.0036	CcSEcCtD
Labetalol—Rash—Hydroxyurea—head and neck cancer	0.00176	0.00358	CcSEcCtD
Labetalol—Dermatitis—Hydroxyurea—head and neck cancer	0.00175	0.00358	CcSEcCtD
Labetalol—Headache—Hydroxyurea—head and neck cancer	0.00174	0.00356	CcSEcCtD
Labetalol—Pain—Fluorouracil—head and neck cancer	0.00171	0.0035	CcSEcCtD
Labetalol—Muscle spasms—Docetaxel—head and neck cancer	0.0017	0.00348	CcSEcCtD
Labetalol—Nausea—Hydroxyurea—head and neck cancer	0.00165	0.00337	CcSEcCtD
Labetalol—Feeling abnormal—Fluorouracil—head and neck cancer	0.00165	0.00337	CcSEcCtD
Labetalol—Flurbiprofen—PTGS2—head and neck cancer	0.0016	0.0655	CrCbGaD
Labetalol—Urticaria—Fluorouracil—head and neck cancer	0.00159	0.00325	CcSEcCtD
Labetalol—Syncope—Docetaxel—head and neck cancer	0.00159	0.00324	CcSEcCtD
Labetalol—Body temperature increased—Fluorouracil—head and neck cancer	0.00158	0.00323	CcSEcCtD
Labetalol—Palpitations—Docetaxel—head and neck cancer	0.00157	0.0032	CcSEcCtD
Labetalol—Loss of consciousness—Docetaxel—head and neck cancer	0.00156	0.00318	CcSEcCtD
Labetalol—Hypertension—Docetaxel—head and neck cancer	0.00153	0.00312	CcSEcCtD
Labetalol—Hypersensitivity—Fluorouracil—head and neck cancer	0.00148	0.00301	CcSEcCtD
Labetalol—Confusional state—Docetaxel—head and neck cancer	0.00146	0.00298	CcSEcCtD
Labetalol—Oedema—Docetaxel—head and neck cancer	0.00145	0.00295	CcSEcCtD
Labetalol—Anaphylactic shock—Docetaxel—head and neck cancer	0.00145	0.00295	CcSEcCtD
Labetalol—Ketoprofen—PTGS2—head and neck cancer	0.00145	0.0593	CrCbGaD
Labetalol—Shock—Docetaxel—head and neck cancer	0.00142	0.0029	CcSEcCtD
Labetalol—Pruritus—Fluorouracil—head and neck cancer	0.00142	0.00289	CcSEcCtD
Labetalol—Diarrhoea—Fluorouracil—head and neck cancer	0.00137	0.0028	CcSEcCtD
Labetalol—Hypotension—Docetaxel—head and neck cancer	0.00135	0.00276	CcSEcCtD
Labetalol—Dizziness—Fluorouracil—head and neck cancer	0.00133	0.0027	CcSEcCtD
Labetalol—Paraesthesia—Docetaxel—head and neck cancer	0.0013	0.00265	CcSEcCtD
Labetalol—Dyspnoea—Docetaxel—head and neck cancer	0.00129	0.00263	CcSEcCtD
Labetalol—Somnolence—Docetaxel—head and neck cancer	0.00129	0.00262	CcSEcCtD
Labetalol—Vomiting—Fluorouracil—head and neck cancer	0.00127	0.0026	CcSEcCtD
Labetalol—Dyspepsia—Docetaxel—head and neck cancer	0.00127	0.0026	CcSEcCtD
Labetalol—Rash—Fluorouracil—head and neck cancer	0.00126	0.00258	CcSEcCtD
Labetalol—Dermatitis—Fluorouracil—head and neck cancer	0.00126	0.00258	CcSEcCtD
Labetalol—Headache—Fluorouracil—head and neck cancer	0.00126	0.00256	CcSEcCtD
Labetalol—Fatigue—Docetaxel—head and neck cancer	0.00125	0.00254	CcSEcCtD
Labetalol—Pain—Docetaxel—head and neck cancer	0.00124	0.00252	CcSEcCtD
Labetalol—Constipation—Docetaxel—head and neck cancer	0.00124	0.00252	CcSEcCtD
Labetalol—Feeling abnormal—Docetaxel—head and neck cancer	0.00119	0.00243	CcSEcCtD
Labetalol—Nausea—Fluorouracil—head and neck cancer	0.00119	0.00243	CcSEcCtD
Labetalol—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00118	0.00241	CcSEcCtD
Labetalol—Abdominal pain—Docetaxel—head and neck cancer	0.00114	0.00233	CcSEcCtD
Labetalol—Body temperature increased—Docetaxel—head and neck cancer	0.00114	0.00233	CcSEcCtD
Labetalol—Hypersensitivity—Docetaxel—head and neck cancer	0.00107	0.00217	CcSEcCtD
Labetalol—Asthenia—Docetaxel—head and neck cancer	0.00104	0.00212	CcSEcCtD
Labetalol—Pruritus—Docetaxel—head and neck cancer	0.00102	0.00209	CcSEcCtD
Labetalol—Diarrhoea—Docetaxel—head and neck cancer	0.00099	0.00202	CcSEcCtD
Labetalol—Dizziness—Docetaxel—head and neck cancer	0.000957	0.00195	CcSEcCtD
Labetalol—Vomiting—Docetaxel—head and neck cancer	0.00092	0.00188	CcSEcCtD
Labetalol—Rash—Docetaxel—head and neck cancer	0.000912	0.00186	CcSEcCtD
Labetalol—Dermatitis—Docetaxel—head and neck cancer	0.000911	0.00186	CcSEcCtD
Labetalol—Headache—Docetaxel—head and neck cancer	0.000906	0.00185	CcSEcCtD
Labetalol—Nausea—Docetaxel—head and neck cancer	0.000859	0.00175	CcSEcCtD
